Cargando…
How reliable are ICER’s results published in current pharmacoeconomic literature? The controversial issue of price confidentiality
Pharmacoeconomic data are widely used along drug life cycle for supporting decision-making processes on research and development, pricing and reimbursement, and market access. In this context, the incremental cost-effectiveness ratio (ICER) is the gold standard of either cost-effectiveness analyses...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AboutScience
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768610/ https://www.ncbi.nlm.nih.gov/pubmed/36628320 http://dx.doi.org/10.33393/grhta.2022.2350 |